Related Experiment Video
Updated: Aug 1, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Insights
Early newborn screening for Tyrosinemia type 1 (TT1) significantly improves outcomes. Prompt identification allows for management as a chronic condition, enhancing quality of life for affected children.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Tyrosinemia type 1 (TT1) is a severe inherited metabolic disorder.
- Historically, TT1 led to poor prognoses, including organ failure and neurologic crises in infants.
- Advances in newborn screening have dramatically altered the outlook for children with TT1.
Purpose of the Study:
- To provide an overview of nursing care for Tyrosinemia type 1.
- To offer specific recommendations for reducing complications and improving the quality of life for children with TT1.
Main Methods:
- Early identification of TT1 through newborn screening.
- Measurement of succinylacetone via tandem mass spectrometry for diagnosis.
- Comprehensive management strategies including genetic counseling, dietary adjustments, and pharmacotherapy.
Main Results:
- Improved prognosis for children diagnosed with TT1 via newborn screening.
- Management of TT1 as a chronic disease is now feasible.
- Nursing care, informed by pathophysiology, is crucial for successful management.
Conclusions:
- Early detection and management transform TT1 from a fatal condition to a manageable chronic disease.
- Understanding TT1 pathophysiology is essential for effective nursing interventions.
- Targeted nursing care can significantly reduce complications and enhance patient quality of life.
Abstract:
Tyrosinemia type 1 (TT1) is an inherited metabolic disease that can be fatal when not detected early by newborn screening. In the past, children with TT1 had a poor prognosis due to organ failure and neurologic crisis during infancy. Recent improvements in newborn screening have changed the prognosis of affected children. Measurement of succinylacetone by tandem mass spectrometry provides early identification and the opportunity to manage TT1 as a chronic disease. Treatment includes genetic counseling, dietary management, pharmacotherapy, metabolic crisis prevention, and whole organ transplant. Nursing care is critical to successful management when it is based on a clear understanding of the pathophysiology. This overview of nursing care will provide specific recommendations to reduce complications and enhance the quality of life for children with TT1.
Related Concept Videos
Myocarditis IV: Nursing Management
Dysrhythmias VII: Nursing Management of Dysrhythmias
Cardiomyopathy VI: Nursing Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease IV: Nursing Management
Type I Diabetes I: Introduction
